Simvastatin attenuates sympathetic hyperinnervation to prevent atrial fibrillation during the postmyocardial infarction remodeling process. J Appl Physiol 113: 1937-1944, 2012. First published September 13, 2012 doi:10.1152/japplphysiol.00451.2012.-Statin, as a 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor, has been shown to prevent atrial fibrillation (AF) due to its anti-inflammatory and antioxidant effects. However, it is still not known whether statin can improve autonomic remodeling to prevent AF. In the present study, using an in vivo rat myocardial infarction (MI) model, we aimed to test whether simvastatin can attenuate nerve sprouting and sympathetic hyperinnervation to prevent AF during the post-MI remodeling process. Our data demonstrate that simvastatin, delivered 3 days after MI for 4 wk, can result in significant decreases in plasma levels of both TNF-␣ (239 Ϯ 23 pg/ml) and IL-1 (123 Ϯ 11 pg/ml) compared with MI rats without therapy (TNF-␣, 728 Ϯ 57 pg/ml; IL-1, 213 Ϯ 21 pg/ml; P Ͻ 0.05), which, however, were still higher than sham-operated rats (TNF-␣, 194 Ϯ 20 pg/ml; IL-1, 75 Ϯ 8 pg/ml; P Ͻ 0.05). The similar pattern of changes in inflammation responses was also observed in TNF-␣ and IL-1 protein expression in the left atrium free wall. The suppressed inflammation responses were associated with reduced superoxide and malondialdehyde generation in the atrium. These changes account for decreases in neural growth factor expression at levels of both mRNA (1.2 Ϯ 0.09 AU vs. MI group, 1.78 Ϯ 0.16 AU) and protein (1.57 Ϯ 0.17 AU vs. MI group, 2.24 Ϯ 0.19 AU; P Ͻ 0.05), thus resulting in reduced nerve sprouting and sympathetic hyperinnervation. Accordingly, the rate adaptation of the atrial effective refractory period also recovered, leading to the decreased inducibility of AF. These data suggest that simvastatin administration after MI can prevent AF through reduced sympathetic hyperinnervation. atrial fibrillation; autonomic remodeling; inflammation; statin ATRIAL FIBRILLATION (AF) IS a common cardiac arrhythmia in clinical practice, which is associated with a higher mortality as well as an increased morbidity due to a significantly higher incidence of stroke, congestive heart failure, and tachycardiainduced cardiomyopathy, leading to an impaired quality of life (4). In the patients with myocardial infarction (MI), a cardiacremodeling process often results in a high incidence of AF (3).A growing body of evidence shows that inflammation and/or oxidative stress play an important role in the pathological process of AF (20); however, the underlying mechanism via which inflammation causes AF is still not well known. Interestingly, in a tachycardiac pacing-induced AF animal model, there shows a significant increase in nerve sprouting and sympathetic hyperinnervation, characterized by a higher density of GAP-43-and tyrosine hydroxylase (TH)-positive staining nerves in the atrium (6, 27). Furthermore, nerve sprouting and sympathetic hyperinnervation are also observed in MI animal models where GAP-43...